Business Context and Reporting Period
This Form 6-K filing is submitted by GlaxoSmithKline plc, GlaxoSmithKline Capital Inc., and GlaxoSmithKline Capital plc for the month of May 2008. The report serves to incorporate by reference a specific exhibit into the registrants' Registration Statement on Form F-3 (File No. 333-149531).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing designed to attach a specific calculation to a registration statement rather than a comprehensive financial report.
Material Changes
The filing text does not provide data regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. The primary content is the incorporation of Exhibit 12.1, titled "Statement of Computation of Ratio of Earnings to Fixed Charges," into the Form F-3 registration statement.
Investor Verification Checklist
- Verify the contents of Exhibit 12.1 (Statement of Computation of Ratio of Earnings to Fixed Charges) referenced in the filing.
- Review the associated Registration Statement on Form F-3 (File No. 333-149531) for the full context of the securities offering.
- Confirm the specific fixed charge obligations and earnings figures used in the ratio computation, as these are not detailed in the Form 6-K cover page.